🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Poland / NCT07511946
Starting soon Observational

Bruxism Induced by Obstructive Sleep Apnoea.

NCT07511946 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2026-09
Last updated
2026-07-22

Condition(s) studied

Sleep Apnea Syndrome, ObstructiveBruxism, Sleep-RelatedUpper Respiratory Tract Illness

Investigational drug(s) / intervention(s)

Upper airway volume assessment using Cone-Beam Computed Tomography (CBCT) and PolysomnographyUpper airway volume assessment using Cone-Beam Computed Tomography (CBCT)

Upper airway volume assessment using Cone-Beam Computed Tomography (CBCT) and Polysomnography: Patients in the study group will undergo validated questionnaires assessing psycho-emotional well-being and selected aspects related to the functioning of the stomatognathic system, upper airway volume assessment using CBCT tomography and polysomnography.

Upper airway volume assessment using Cone-Beam Computed Tomography (CBCT): Patients in the control group will undergo validated questionnaires assessing psycho-emotional well-being and selected aspects related to the functioning of the stomatognathic system, upper airway volume assessment using CBCT tomography.

Study summary

The relationship between obstructive sleep apnea (OSA), sleep bruxism, and temporomandibular disorders is becoming clearer, but data on how upper airway volume affects bruxism due to OSA is limited. Recent studies have shown that Cone-Beam Computed Tomography (CBCT) accurately images the upper airway, enabling analysis of its volume and its potential impact on bruxism. CBCT uses low radiation doses, significantly lower than harmful levels, making it a safe method for such assessments. Understanding these relationships can inform clinical practices for managing sleep bruxism, which affects 21% of the global population. The study aims to explore how upper airway volume influences the intensity of sleep bruxism related to OSA.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * age equal to/greater than 18 years * moderate or high risk of sleep apnea according to the STOP-Bang questionnaire * presence of bruxism symptoms in the oral cavity according to the current international consensus on bruxism * positive history of bruxism during sleep Exclusion Criteria: * refusal to participate in the study * pregnancy * breastfeeding * presence of severe mental illness * alcohol and/or drug addiction * taking medications that affect the neuromuscular and/or respiratory systems * severe systemic diseases such as cancer * severe neurological and autoimmune diseases * multiple missing teeth * edentulism in the upper and/or lower jaw

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Uniwersyteckie Centrum Stomatologiczne Wroclaw Dolny Śląsk

More Wroclaw Medical University trials in Poland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07511946 on ClinicalTrials.gov ↗ ← All trials in Poland